Trial Profile
Skeletal Histomorphometry in Patients on Teriparatide or Zoledronic Acid Therapy.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Teriparatide (Primary) ; Zoledronic acid
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- Acronyms SHOTZ
- Sponsors Eli Lilly and Company
- 05 Oct 2013 Twenty-four month results presented at the 35th Annual Meeting of the American Society for Bone and Mineral Research.
- 15 Oct 2012 Results from this trial presented at the 34th Annual Meeting of the American Society for Bone and Mineral Research (ASBMR), according to an Eli Lilly media release.
- 22 Jun 2012 Actual end date (April 2012) added as reported by ClinicalTrials.gov.